GBA1 and Parkinson disease: In contrast, the protective effect of aspirin on the AAO of patients with GBA1-PD was not as pronounced, indicating that the neuroinflammatory mechanisms leading to neurodegeneration might diverge from patients with idiopathic PD or be masked by the genetic susceptibility in GBA1-PD.